Invention Grant
- Patent Title: Hydrochloric acid salt of (6bR,10aS)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxaline
-
Application No.: US16594603Application Date: 2019-10-07
-
Publication No.: US11407751B2Publication Date: 2022-08-09
- Inventor: John Charles Tomesch , Peng Li , Qiang Zhang , Andrew S. Thompson
- Applicant: INTRA-CELLULAR THERAPIES, INC.
- Applicant Address: US NY New York
- Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee Address: US NY New York
- Agency: Hoxie & Associates LLC
- Main IPC: C07D471/16
- IPC: C07D471/16 ; C07D471/04
![Hydrochloric acid salt of (6bR,10aS)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxaline](/abs-image/US/2022/08/09/US11407751B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides methods for the preparation of substituted heterocycle fused gamma-carbolines, such as Formula 2J, as shown below, intermediates useful in producing them and methods for producing such intermediates and such heterocycle fused gamma-carbolines, and as further defined herein:
Public/Granted literature
- US20200087305A1 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS Public/Granted day:2020-03-19
Information query